Lithotripsy Device Market Demonstrates Long-Term Growth Potential At 6.5% CAGR

The lithotripsy device market is on the cusp of notable expansion as healthcare increasingly embraces minimally invasive technologies. Advances in treatment methods and growing demand for outpatient procedures are setting the stage for this sector's growth through the end of the decade. Below is a detailed overview of the market's expected size, key players, emerging trends, and segmentation.

Anticipated Market Size and Growth of the Lithotripsy Device Industry
The global lithotripsy device market is projected to reach $2.61 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.5%. This expansion is driven by a rising preference for minimally invasive urology treatments, ongoing innovations in laser and ultrasound technologies, increased volumes of outpatient surgeries, and the development of urology care infrastructure. Additionally, the market benefits from the growing use of portable lithotripsy systems. Key trends during this period include a shift toward non-invasive stone treatment techniques, wider adoption of laser-based systems, preference for outpatient procedures, growth in compact and mobile devices, and a strong focus on improving treatment accuracy.

Download a free sample of the lithotripsy device market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10662&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Companies Shaping the Lithotripsy Device Market
The lithotripsy device industry features several prominent companies, including Boston Scientific Corporation, Cook Medical LLC, Lumenis Ltd., EDAP TMS S.A., Dornier MedTech GmbH, Allengers Medical Systems Limited, DirexGroup, Medispec Ltd., Elmed Medical Systems Ltd., Convergent Laser Technologies, MTS Medical, NIDHI Meditech Systems, Karl Storz SE & Co. KG, Technomed Systems Private Limited, Shenzhen Wikkon Medical Apparatus Co. Ltd., Inceler Medikal Ltd. Sti, C. R. Bard Inc., E.M.S. Electro Medical Systems S.A., MACHIDA Endoscope Co. Ltd., and Aymed Medical Technology Co. Ltd.

Strategic Moves in the Market: Johnson & Johnson's Acquisition
In May 2024, Johnson & Johnson, a US-based leader in medical devices and pharmaceuticals, acquired Shockwave Medical for an undisclosed sum. This acquisition aims to strengthen Johnson & Johnson's cardiovascular portfolio by incorporating Shockwave Medical's innovative solutions for treating calcified cardiovascular disease. Shockwave Medical, which is headquartered in the US, is a key supplier of lithotripsy devices, and this move supports the expansion of minimally invasive treatment options in the cardiovascular and urology sectors.

View the full lithotripsy device market report:
https://www.thebusinessresearchcompany.com/report/lithotripsy-device-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Technology Trends Driving Lithotripsy Innovation
Industry players are increasingly focused on developing advanced, less invasive technologies to replace traditional shock wave methods. A noteworthy innovation is the non-invasive ultrasound lithotripsy system, which uses low-amplitude ultrasound waves to fragment kidney stones without the need for anesthesia, thereby reducing patient discomfort.

For example, in April 2025, US-based Sonomotion Inc. completed patient enrollment in a pivotal clinical trial for its Break WaveTM System. This technology enables kidney stone treatment in fully awake patients without resorting to conventional shockwave or surgical procedures. When combined with SonoMotion's Stone ClearTM device for clearing residual fragments, it offers a comprehensive and patient-friendly stone management solution. The Break WaveTM System promises enhanced comfort, improved treatment efficiency, and potential reductions in hospital stays and overall procedure costs.

Overview of Lithotripsy Device Market Segments
The lithotripsy device market is categorized based on the following segments:

By Type:
- Extracorporeal Shock Wave Lithotripsy Devices
- Intracorporeal Lithotripsy Devices

By Applications:
- Kidney Stones
- Ureteral Stones
- Pancreatic Stones
- Bile Duct Stones
- Other Applications

By End-User:
- Hospitals
- Ambulatory Surgical Centers
- Other End Users

Detailed subsegments include:

For Extracorporeal Shock Wave Lithotripsy Devices:
- Electrohydraulic Lithotripsy Devices
- Electromagnetic Lithotripsy Devices
- Piezoelectric Lithotripsy Devices

For Intracorporeal Lithotripsy Devices:
- Laser Lithotripsy Devices
- Ultrasound Lithotripsy Devices
- Mechanical Lithotripsy Devices

This segmentation offers a comprehensive framework for understanding the diverse range of technologies, clinical applications, and user environments within the lithotripsy device market.

Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.